
    
      Investigators will test if exoskeleton-assisted ambulation confers skeletal benefits in a
      dose-dependent fashion. Investigators also will test if reintroduction of ambulation will be
      associated with improvements in quality of life due to improvements in mood, pain, and
      functional connectivity of emotional networks in the brain.
    
  